search
Back to results

Cervical I/F Cage for Anterior Cervical Fusion

Primary Purpose

Cervical Intervertebral Disc Degeneration

Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Cervical I/F Cage
Autograft or allograft with a plate, or autograft alone.
Sponsored by
DePuy Spine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cervical Intervertebral Disc Degeneration focused on measuring fusion, cervical, spine

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Persistent recurrent neck and/or shoulder and arm pain refractory to 6 weeks of non-surgical therapy. Radiographic evidence of significant disc degeneration at one or two adjacent cervical levels (C4-7) Exclusion Criteria: Significant degeneration at more than two cervical levels, Prior surgical treatment of the cervical spine; laminotomy or foraminotomy allowed, Gross instability due to trauma, Disability in the lumbar spine, Infection in the disc or spine, past or present, Any active infection at time of surgery, Tumor in the spine, Significant osteoporosis or metabolic bone disease, Pregnant, lactating or wishes to become pregnant within duration of the study, Refusal to accept the use of autograft tissue.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Cervical Cage

    Graft Spacer

    Arm Description

    Cervical I/F Cage

    Autograft or allograft with a plate, or autograft alone.

    Outcomes

    Primary Outcome Measures

    Fusion Status
    Neck Disability Index
    Neurological Status
    Secondary Surgical Interventions

    Secondary Outcome Measures

    Adverse Events
    Donor Site Pain
    Neck Pain
    Arm Pain
    Disc Space Height
    Sagittal Alignment
    SF-36, Health Related Quality of Life

    Full Information

    First Posted
    September 13, 2005
    Last Updated
    May 22, 2014
    Sponsor
    DePuy Spine
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00215293
    Brief Title
    Cervical I/F Cage for Anterior Cervical Fusion
    Official Title
    A Randomized Multi-Center Study to Evaluate the Safety and Efficacy of the Cervical I/F Cage for Anterior Cervical Fusion
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2014
    Overall Recruitment Status
    Completed
    Study Start Date
    August 2000 (undefined)
    Primary Completion Date
    October 2007 (Actual)
    Study Completion Date
    October 2007 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    DePuy Spine

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to determine the clinical success of the Cervical I/F Cage in treatment of one or two adjacent levels of degenerative disc disease of the cervical spine compared with standard of care treatment using either autograft, autograft with a plate or allograft with a plate
    Detailed Description
    This is a prospective randomized multi-center clinical trial to assess the safety and efficacy of the investigational device, Cervical I/F Cage for fusion in one or two adjacent levels of the cervical spine. Patients will be randomly assigned in a ration of 1:1 between the investigational and control groups. Comparison: The device will be compared to a control group consisting of the 3 accepted standard of care treatments (autograft, autograft with an anterior plate, or allograft with an anterior plate). For two level fusions, the control group will be limited to autograft with a plate or allograft with a plate. Based on the current literature, it is believed that there is no difference between the three treatments in terms of clinical success, fusion success, or safety issues. However, amongst the investigators there are preferred treatments. Each investigator will choose one or more of the control treatments at study initiation. Patients will then be randomized in a 1:1 Cage:control randomization schema. Approximately 240 subjects will be enrolled at 20 sites. Eligible patients will have symptomatic degeneration of one or two adjacent cervical discs, have failed six weeks of non-surgical treatment, have sufficiently severe enough symptoms to warrant surgery, and have had no prior fusion surgery on the cervical spine.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cervical Intervertebral Disc Degeneration
    Keywords
    fusion, cervical, spine

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    240 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Cervical Cage
    Arm Type
    Experimental
    Arm Description
    Cervical I/F Cage
    Arm Title
    Graft Spacer
    Arm Type
    Active Comparator
    Arm Description
    Autograft or allograft with a plate, or autograft alone.
    Intervention Type
    Device
    Intervention Name(s)
    Cervical I/F Cage
    Intervention Type
    Device
    Intervention Name(s)
    Autograft or allograft with a plate, or autograft alone.
    Primary Outcome Measure Information:
    Title
    Fusion Status
    Time Frame
    24 months
    Title
    Neck Disability Index
    Title
    Neurological Status
    Title
    Secondary Surgical Interventions
    Secondary Outcome Measure Information:
    Title
    Adverse Events
    Title
    Donor Site Pain
    Title
    Neck Pain
    Title
    Arm Pain
    Title
    Disc Space Height
    Title
    Sagittal Alignment
    Title
    SF-36, Health Related Quality of Life

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Persistent recurrent neck and/or shoulder and arm pain refractory to 6 weeks of non-surgical therapy. Radiographic evidence of significant disc degeneration at one or two adjacent cervical levels (C4-7) Exclusion Criteria: Significant degeneration at more than two cervical levels, Prior surgical treatment of the cervical spine; laminotomy or foraminotomy allowed, Gross instability due to trauma, Disability in the lumbar spine, Infection in the disc or spine, past or present, Any active infection at time of surgery, Tumor in the spine, Significant osteoporosis or metabolic bone disease, Pregnant, lactating or wishes to become pregnant within duration of the study, Refusal to accept the use of autograft tissue.

    12. IPD Sharing Statement

    Learn more about this trial

    Cervical I/F Cage for Anterior Cervical Fusion

    We'll reach out to this number within 24 hrs